Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications [Corrigendum]
Shen J, Goodkin ML, Tong W, Attar M. Clin Ophthalmol. 2017;11:1761–1767.On page 1765, Clinical correlation with evidence for use of bimatoprost twice daily in humans section, second column, last line, “−5.4 to −5.6 mm Hg” should have read “...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2018-08-01
|
| Series: | Clinical Ophthalmology |
| Online Access: | https://www.dovepress.com/corrigendum-ocular-pharmacokinetics-and-tolerability-of-bimatopro-peer-reviewed-article-OPTH |